Convisero mentor Boaz Wachtel has researched on ibogaine as a treatment over the course of his career and has been an active advocate of its use (such as in this published September 2024 Haaretz article) for such cases described below.

The article released just on December 16, 2024 below shows ibogaine’s use gaining momentum in mainstream treatment options.

“Unable to find effective treatments at home, veterans with brain-injury symptoms are going abroad for psychedelics like ibogaine that are illegal in the U.S.” Full article found at the New York Times linked here.

Excerpt below:

Their drug of choice is ibogaine, an alkaloid derived from the bark of the iboga tree. It is illegal in the United States and has a reputation for causing dark, harrowing trips. But research on animals has shown it can spur the release of natural proteins in the brain that repair and reconfigure neural networks. That leads some researchers to consider it a potential treatment for traumatic brain injury.
Psychedelic clinics typically administer ibogaine in a single dose, followed the next day by a dose of the poison of the Sonoran desert toad, called 5-MeO-DMT, a powerful short-acting psychedelic that tends to give users an overwhelming feeling of spiritual connection, earning it the nickname “the God molecule.”
In most cases, the patient uses each drug just once, and participates in psychotherapy beforehand and afterward. Navy SEALs in particular have become involved with ibogaine, in part because several ibogaine clinics in Mexico are just a few miles from a major SEAL base in Southern California. Most wait until they have left the Navy, but dozens who are still on active duty make the trip each year, several SEALs said.